<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>专利迷幻学的比赛刚刚开始 The Race to Patent Psychedelics Is Just Getting Started</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">The Race to Patent Psychedelics Is Just Getting Started<br/>专利迷幻学的比赛刚刚开始 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-03-08 02:20:54</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/3/6aff4dc165b2fb6ca22f9f1f7d631a40.jpeg"><img src="http://img2.diglog.com/img/2021/3/6aff4dc165b2fb6ca22f9f1f7d631a40.jpeg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The author and podcast host Tim Ferriss has done his share of heavy lifting when it comes to supporting and promoting research on psychedelic drugs. He’s invested millions of his own, and also  organized half the $17 million in commitments it took to start up the Johns Hopkins Center for Psychedelic &amp; Consciousness Research.</p><p>作者和播客主持人Tim Ferriss在支持和促进迷幻药物的研究方面，他的繁重举重已经完成。他正在投入了数百万他自己，并且还组织了一半的1700万美元的承诺，以启动雪橇霍普·霍普约翰霍普金斯中心;意识研究。</p><p>  While his efforts highlight the reality that psychedelic therapy, like any other medical treatment, requires significant amounts of money for research, Ferriss recently tweeted his apprehension about a side effect of the growing money-generating psychedelic market.</p><p>  虽然他的努力突出了迷幻治疗的现实，就像任何其他医疗一样，需要大量的研究资金，但铁脂最近发布了他对不断增长的迷人迷幻市场的副作用的担忧。</p><p>  &#34;I am very concerned by the patent land grab warming up in the for-profit psychedelic world,” he  wrote, asking publicly if there was any coalition of pro-bono lawyers who could intervene “when companies attempt to secure broad patents that could hinder scientific research, reasonable competition…and so on?”</p><p>  ＆＃34;我非常关心的是在营利性迷幻世界中预热的专利土地，“他写道，如果有任何可以介入的Pro-Bono律师联盟，那么在公司试图确保广泛的专利这可能阻碍科研，合理的竞争......等等？“</p><p>  Patent announcements are hard to miss in the psychedelic field these days. Most recently, as Troy Farah  wrote in Future Human, the biotech startup CaaMTech was granted a patent for the combination of cannabis and psilocybin. A patent application from mental health company Compass Pathways  garnered attention for including claims on very basic elements of psychedelic psychotherapy—from holding hands to using soft furniture.</p><p>  这些天，专利公告很难错过迷幻领域。最近，正如Troy Farah在未来的人类写的那样，Biotech Startup Caamtech被授予大麻和Psilocybin组合的专利。来自心理健康公司指南针的专利申请表达了在迷幻心理治疗的非常基本元素中引起的注意力 - 从牵手使用软家具。</p><p>   A patent gives an individual or company ownership over an invention, and then prevents others from using their invention without licensing it. The patent office looks at scientific literature and prior patents to determine if an invention should be granted a patent, but the amount of psychedelic knowledge might not be reflected in these resources since psychedelics have been illegal and operating underground.</p><p>   专利给出了对本发明的个人或公司所有权，然后防止他人使用他们的发明而不许可。专利局看着科学文献和现有专利，以确定是否应该授予发明的专利，但由于迷幻学一直是非法和地下操作，因此可能不会反映在这些资源中的迷幻知识。</p><p>  In many respects, the for-profit psychedelic field is behaving the same as other biotech companies have before—they’re taking notice of potentially beneficial compounds and research, and trying to patent “novel” uses to build profitable patent libraries. The issue that&#39;s arising is partly a philosophical one: The  experiences that many people have taking psychedelics  directly contradict this shift towards ownership, profit, and exclusion. More practically, as researchers continue to show promising results from academic trials on a myriad of mental health disorders, there’s valid concern about psychedelics becoming price gouged or monopolized through intellectual property (IP).</p><p>  在许多方面，营利性迷幻领域与其他生物技术公司一起表现相同 - 他们在之前注意到潜在的有益化合物和研究，并试图专利“小说”用于建立有利可图的专利文库。 ＆＃39的问题是部分是一个哲学之一：许多人服用迷幻的经历直接与所有权，利润和排斥的转变相矛盾。更实际上，随着研究人员继续表现出对无数心理健康障碍的学术试验的有希望的结果，对迷幻学令人有效的担忧，令人有效地通过知识产权（IP）挖掘或垄断。</p><p>  There&#39;s notable disagreement about how to move forward from the field&#39;s major players. Rick Doblin, the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS),  responded to Ferriss&#39; tweet to say that MAPS “has recently engaged patent attorneys to assist in strengthening our anti-patent strategy for uses of MDMA, and to prepare easily accessible information for patent examiners so patents will not be issued in the first place.”</p><p>  有关如何从字段中向前举行的显着分歧和＃39; Rick Doblin，MulticiCISINARIC学习协会的创始人和执行董事（地图），回应了Ferriss＆＃39;推文说，地图“最近聘请了专利律师，协助加强我们对MDMA的使用的反专利战略，并为专利审查员准备轻松访问的信息，因此不得首先发布专利。” </p><p>  Doblin also wrote that MAPS will not seek to patent any uses of MDMA for clinical use, “and will actively challenge patents on MDMA-assisted therapy that seek to privatize information already in the public domain that don’t represent actual innovations.” Similarly, the non-profit Usona Institute has taken an &#34;open science&#34; approach by not filing for patents.</p><p>Doblin还写了地图不会寻求专利的MDMA用于临床使用的用途，并将积极挑战关于MDMA辅助治疗的专利，该辅助治疗旨在私有化已经在不代表实际创新的公共领域的信息。“同样，非营利性救济学院已经采取了一个＆＃34;开放科学＆＃34;不提起专利的方法。</p><p>  Christian Angermayer, the psychedelic investor who helped fund Compass Pathways and co-founded the company ATAI Life Sciences, took another view, responding to Ferriss: “Tim I am [a] HUGE fan of your work, but on this topic you are incredibly misguided.” He went on to say that while Ferriss has donated a “few million” dollars to the psychedelic research space, “It’s a drop in the ocean relative to what’s needed.”</p><p>  Christian Angermayer，帮助资助指南针途径并共同创立了公司Atai Life Sciences的迷幻投资者，拍摄了另一个看法，回应了Ferriss：“Tim我是[A]你的工作巨大的粉丝，但是在这个主题上你是令人难以置信的误导。“他继续说，虽然铁人士捐赠了“几百万”美元的迷幻研究空间，“它相对于需要的东西是海洋中下降。”</p><p>  Angermayer also  recently said in an interview that he believes that biotech will be one of the best performing asset classes of the next 20 years. “What tech was the last two decades, the next two decades will be biotech,&#34; he said. &#34;50% of my entire portfolio is in biotech.”</p><p>  Angermayer也最近在面试中表示，他认为Biotech将成为未来20年的最佳资产课程之一。 “过去二十年来的是什么技术，接下来的二十年将是生物技术，＆＃34;他说。 ＆＃34;我整个投资组合的50％是生物技术。“</p><p>  Patent applications are secret for 18 months, and what we&#39;ve seen is likely only the tip of the psychedelic patent iceberg. Psilocybin Alpha, a publication geared towards investors in psychedelic medicine, has a  Psilocybin Patent Tracker,  an MDMA Patent Tracker, and a  DMT Patent Tracker, so that anyone can keep as up to date as possible on what’s being filed.</p><p>  专利申请是18个月的秘密，我们所看到的可能只是迷幻专利冰山的尖端。 Psilocybin alpha是对迷幻医学投资者的出版物，具有Psilocybin专利跟踪器，MDMA专利跟踪器和DMT专利跟踪器，因此任何人都可以在提交的内容上保持最新状态。</p><p>   To get a sense of what&#39;s out there right now, Motherboard took a look at several pending and granted patents that include psychedelics, to show how diverse these applications can be. Psychedelic compounds appear in patent applications for Philip Morris e-cigarettes, periodontal disease, hair loss, weight loss, and the treatment of food allergies.</p><p>   为了了解现在，主板待了一些待遇和授予包括荧光的专利，以表明这些应用程序的多样化。荧光化合物出现在菲利普莫里斯电子烟，牙周病，脱发，体重减轻和食物过敏的治疗中的专利申请。</p><p>  What’s crucial to understanding some of these applications is that they are not all primarily psychedelic patent applications; they’re patent applications for other inventions that happen to include different psychedelics as an optional or potential part of that invention. Remember: With patent applications, there’s no guarantee that they’ll be granted, and if they are, they could be heavily amended beforehand. Still, what we can see from the wide scope of these applications is that psychedelics are increasingly popping up, and that the &#34;patent land grab&#34; is reaching much farther than just mental health.</p><p>  理解其中一些申请至关重要的是，它们并非所有主要是迷幻专利申请;它们是用于其他发明的专利申请，其恰好包括不同的荧光性作为本发明的可选或潜在部分。请记住：通过专利申请，没有保证他们将被授予，如果是，他们可能会严重修改。尽管如此，我们可以从这些应用程序的广泛范围内看到的是，迷幻越来越突破，而且＆＃34;专利土地抢＆＃34;达到了比心理健康更远。</p><p>   After Graham Pechenik, a patent and IP lawyer,  tweeted that cigarette and tobacco company Philip Morris&#39; patent grants and applications have the largest number of disclosing uses for N,N-DMT &amp; 5-MeO-DMT (different formulations of DMT), he said it caused quite a buzz.</p><p>   在Graham Pechenik，专利和知识产权律师之后，推文卷烟和烟草公司菲利普莫里斯＆＃39;专利授权和应用具有N，N-DMT＆amp的揭示用途最多; 5-Meo-DMT（不同的DMT配方），他说这引起了嗡嗡声。 </p><p>    But there’s some nuance here to unpack: The Philip Morris patents aren’t really patents for “DMT vape pens.” They are patents or applications on various types of e-cigarettes and mechanisms within the e-cigarettes. DMT and 5-MeO-DMT are included in a list of &#34;medicaments&#34; that  could be used in those e-cigarettes.</p><p>但这里有一些细微的谴责：菲利普莫里斯专利不是“DMT Vape钢笔”的专利。它们是关于各种类型的电子卷烟和电子卷烟机制的专利或应用。 dmt和5-meo-dmt包含在＆＃34的列表中;药物＆＃34;可以在那些电子烟中使用。</p><p>  That said, if DMT were legalized, Philip Morris could have grounds to prevent anyone else from putting DMT in Philip Morris devices specifically. “Philip Morris is definitely not patenting a DMT vape pen, specifically,” Pechenik said. “But, it at least shows that they&#39;re aware that this is a compound that could be used.”</p><p>  也就是说，如果DMT合法化，菲利普莫里斯可能会让其他人能够特别地将DMT放在菲利普莫里斯设备中。 “菲利普·莫里斯绝对不是专利的DMT VAPE笔，专利，”Pechenik说。 “但是，至少表明它们＆＃39;重新意识到这是一种可以使用的化合物。”</p><p>  DMT  vape pens don’t currently have any research behind them: It&#39;s unknown whether they are safe, for one, or if they have any other benefits or uses.</p><p>  DMT VAPE PENS目前不会在它们背后进行任何研究：它＆＃39;如果他们有一个，或者如果他们有任何其他好处或用途，他们是安全的。</p><p>  “In essence, I think they’re looking ahead, and want to make sure nobody would be able to say that they’re not infringing because DMT wasn’t in Philip Morris’ patents,&#34; Pechenik said. &#34;And [they] want to stake out the space so that others don’t file their own patents specific to DMT vapes.&#34;</p><p>  “实质上，我认为他们展望未来，并希望确保没有人能够说他们不是侵权，因为DMT不是菲利普莫里斯的专利，＆＃34; Pechenik说。 ＆＃34;和[他们]希望抑制空间，以便其他人不会提交特定于DMT VAPES的自己的专利。＆＃34;</p><p>   In 2018, alternative medicine proponent and doctor Andrew Weil  told Joe Rogan that his cat allergy disappeared after he took LSD. He told CBS journalist Ed Bradley the  same anecdote in 2001: “I took LSD. I was in a wonderful outdoor setting. I felt terrific and, in the midst of this, a cat came up to me and crawled into my lap. I did not have an allergic reaction to it and I never did since.”</p><p>   2018年，替代医学支持者和医生Andrew Weil告诉Joe Rogan，他拍摄了LSD后他的猫过敏消失了。他告诉CBS记者Ed Bradley在2001年同样的轶事：“我拿了LSD。我在一个美妙的户外环境中。我觉得很棒，在这个中间，一只猫来找我，爬进我的腿上。我对它没有过敏反应，我从来没有做过。“</p><p>  He continued to tell Bradley that he thought food allergies were “learned.” ”That gave me the idea that [taking LSD] would be a great way to teach people to unlearn allergies,&#34; he said. (In the same interview he said he wasn’t comfortable being called a shaman or a medical holy man, but that “wizard” was OK.)</p><p>  他继续告诉布拉德利，他认为食物过敏是“学到的。” “这给了我一个想法，[服用LSD]将是教人们忘记过敏的好方法，＆＃34;他说。 （在同一采访中，他说他不舒服被称为萨满或医疗圣人，但“巫师”还可以。）</p><p>   Food allergies are incredibly complex. There’s no current research on psychedelics for food allergies; the most promising food allergy treatment is oral immunotherapy, which exposes you to tiny amounts of the food you’re allergic to in order to become desensitized to it. Another  innovative approach still being researched attempts to utilize compounds made by gut bacteria.</p><p>   食物过敏令人难以置信的复杂。对食物过敏的迷幻学没有目前的研究;最有前景的食物过敏治疗是口服免疫疗法，这使您暴露于您过敏的少量食物，以便将其脱敏。另一种创新方法仍在研究尝试利用肠细菌制成的化合物。 </p><p>  But there is one public patent application making claims on psychedelics&#39; ability to treat food allergies. The patent application even makes claims around severe allergic reactions: “Food allergy conditions may, after exposure to an allergen, cause an anaphylactic condition in a subject. Accordingly, the methods of the present disclosure may, in some instances, treat, including prevent or lessen the severity of, anaphylaxis in a subject following exposure to an antigen.”</p><p>但是有一个公共专利申请对迷幻学案件索赔＆＃39;能够治疗食物过敏。专利申请甚至使得严重过敏反应的权利要求：“食物过敏条件可能在暴露于过敏原后可能导致受试者的过敏性条件。因此，本公开的方法可以在某些情况下治疗，包括预防或减少在暴露于抗原之后的受试者的过敏性的严重程度。“</p><p>  The  food allergy application was filed by the investment firm Palo Alto Investors. Joon Yun, the president and managing partner, described the group  on his website as a “team of practicing physicians run one of the biggest healthcare investment shops in the country. We make long-term investments for high-net-worth and institutional investors based on original, deep, fundamental research. We don’t rent stocks. We own them.”</p><p>  投资公司Palo Alto投资者提出了食物过敏申请。 Joon Yun总裁兼管理伙伴，描述了他网站上的小组作为“练习医生的团队运行该国最大的医疗投资商店之一。我们为基于原创，深，基础研究的高净值和机构投资者进行长期投资。我们不租股票。我们拥有它们。“</p><p>  How can a patent application be filed for something that has yet to be proven? Pechenik said that the U.S. has pretty liberal laws around providing evidence for your patent claims. All that is required in an application is a  description of your invention so that someone could make and use it. Then, a patent application can include something called a “prophetic example,” which can be found in this food allergy application. Their “example,” shown below, is not actually an experiment that took place.</p><p>  如何向尚未证明的东西提交专利申请？ Pechenik表示，美国在提供专利索赔的证据周围具有相当的自由法律。应用程序中所需的只是对您的发明描述，以便有人可以制作和使用它。然后，专利申请可以包括称为“预言示例”的东西，其可以在该食品过敏应用中找到。他们的“示例”如下所示，实际上并不是一个发生的实验。</p><p>  “Basically it’s a prophecy, quite literally, where you just lay out what a research program may look like, and then just prophesize what the results you hope to achieve are,” Pechenik said. He&#39;s worked on cases where a prophetic example was enough to get a patent granted.</p><p>  “基本上这是一个预言，非常简单，你只是铺设了一个研究计划可能看起来像的东西，然后只是预先介绍你希望实现的结果是什么，”Pechenik说。他＆＃39;在预言例子足以获得授予专利的情况下工作。</p><p>  When writing prophetic claims, applicants have to avoid using the past tense. “Doing so, and making people think it’s been done, can actually be inequitable conduct that can render a patent unenforceable,” Pechenik said.</p><p>  在编写预言要求时，申请人必须避免使用过去时态。 “这样做，让人们认为已经完成了，实际上可以不公平行为，这可以使专利无法执行，”Pechenik说。</p><p>  Patent examiners can push back, and try to limit patent claims to be more specific, or gather more evidence. In the most recent back and forth on this patent application, the examiners wrote that the application claims could only include claims on &#34;treating food allergy by LSD,” whereas the original filed application claims included all psychedelics.</p><p>  专利审查员可以推回，并试图限制专利要求更具体，或收集更多的证据。在这项专利申请的最新来回前后来回，审查员写道，申请要求只能包括＆＃34的索赔;处理LSD的食物过敏，而原始的申请索赔包括所有荧光。</p><p>   The application’s amended claims, filed on February 16, 2021, now only include LSD. “This helps the examiner save time, and forces an applicant to pay multiple fees where there’s more than ‘a single invention’ in an application,” Pechenik said. “What will happen now, most likely, is the applicant will file one or more continuation applications to next ask for claims to psilocin or other agents.”</p><p>   该申请经修订的声明，于2021年2月16日提交，现在仅包括LSD。 “这有助于审查员节省时间，并迫使申请人支付在申请中存在超过”一个单一发明“的费用，”Pechenik说。 “现在将发生什么，最有可能的是申请人将提出一个或多个持续应用程序，以便下一步要求对psilocin或其他代理人提出索赔。” </p><p>  David Casimir, a lawyer specializing in intellectual property who has a Ph.D. in biochemistry,  thinks that this patent won&#39;t be issued if it’s examined thoroughly—but he can’t say for certain. “Maybe it would,” he said. “But then what that would be is essentially a very challengeable patent if it is issued as broadly as it&#39;s written right now.”</p><p>David Casimir是一家专门从事博士学位的知识产权的律师。在生物化学中，认为这项专利赢得了＆＃39;如果它彻底审查 - 但他不能说。 “也许会，”他说。 “但是，如果它是广泛的，那么这将是一个非常有挑战性的专利，因为它现在已经＆＃39;”</p><p>  There could be another barrier to this patent application called “anticipation by inherency.” This means that even if you discover something “new,” if it’s been happening &#34;inherently&#34; in the past, you can’t get a patent on it. That means if LSD really does treat food allergies (again—there’s no evidence yet that it does) thousands or more people would have already received this benefit.</p><p>  该专利申请可能还有另一个障碍称为“通过其自身期待”。这意味着即使您发现某些东西“新建”，如果它正在发生＆＃34;固有地＆＃34;在过去，您无法获得专利。这意味着如果LSD真的确实治疗食物过敏（再次 - 没有证据表明它确实会收到这一福利。</p><p>  “This would have happened in the past, even if it’s not in the public literature,” Casimir said. “If the patent office can find evidence to see that someone in the past took a psychedelic drug and had a food allergy, then they should be unpatentable unless they can prove that there&#39;s a specific mechanism that&#39;s being treated here.”</p><p>  “这将发生在过去，即使它不在公共文献中，”卡西米尔说。 “如果专利办公室可以找到证据表明过去的某人患有迷幻药物并有食物过敏，那么他们应该是不可分配的，除非他们可以证明那里的＆＃39;在这里对待的特定机制。“</p><p>   On March 2, NeonMind Biosciences announced in  a press release that it filed four provisional patent applications involving the potential use of psilocybin as a treatment for weight loss. “NeonMind’s proprietary preclinical data shows promise that both low and high dose psilocybin may reduce weight gain and that the reduction in weight gain can occur in a short period of time,” the release said.</p><p>   3月2日，霓虹灯宣布在新闻稿中宣布，它提交了四种临时专利申请，涉及潜在使用Psilocybin作为减肥的治疗方法。 “氖主义的专有临床前数据显示了许多低剂量psilocybin可以减轻体重增加，并且在短时间内可以发生重量增益的减少，”释放说。</p><p>  NeonMind’s pending patent applications include a wide variety of psychedelic compounds, including psilocybin, DMT, and LSD, for treatments including weight loss, obesity, reduction of food cravings, and decreasing food intake.</p><p>  诺曼宁的未决专利申请包括各种各样的迷幻化合物，包括Psilocybin，DMT和LSD，用于治疗，包括减肥，肥胖，食品渴望的减少和降低食物摄入量。</p><p>  This isn’t the first psychedelic patent application we’ve seen for weight loss. In 2019, The Yield Growth Corp.  announced that its subsidiary Flourish Mushroom Labs filed a provisional patent application for the use of psychedelic mushroom compounds for weight loss.</p><p>  这不是我们看到减肥的第一个迷幻专利申请。 2019年，产量增长公司宣布其子公司蓬勃发展的蘑菇实验室提出了临时专利申请，用于使用迷幻蘑菇化合物进行体重减轻。</p><p>  Pechenik said that generally, whoever files a patent application first has priority, but there are many different ways a later patent could differentiate itself from an earlier one—whether it be specific formulation, dose, or patient population. Either way, it looks there will be various attempts to apply psychedelics to different components of weight loss.</p><p>  Pechenik说，通常，无论何种专利申请首先都具有优先权的人，但是有许多不同的方式，后者专利可以从较早的方面区分其自身 - 无论是特定的配方，剂量还是患者人口。无论哪种方式，它看起来会有各种各样的尝试将荧光性应用于减肥的不同组件。 </p><p>   Usually, when a person takes LSD, they commit to an experience of at least six to 12 hours. What if you could stop it early? That’s what the psychedelic company MindMed is trying to patent with its application for an “LSD neutralizer,” a compound called ketanserin.</p><p>通常，当一个人需要LSD时，他们承诺至少六到12个小时的经验。如果你能早起怎么办？这就是迷人的公司思维的思维是试图用它适用于“LSD中和剂”的专利，该化合物称为Ketanserin。</p><p>  LSD is serotonergic, meaning that it binds to serotonin receptors—specifically, one called the 5-HT2A receptor. Ketanserin has the opposite effect on the receptor. One study has previously found that if people took ketanserin  before taking LSD, it prevented the most intense effects of the psychedelic. MindMed is investigating whether or not ketanserin could be used after a person has already taken LSD in order to shorten or end the trip.</p><p>  LSD是Serotonergic，其意味着它与血清素受体结合 - 特别是一种称为5-HT2A受体的受体。 Ketanserin对受体的影响相反。一项研究以前发现，如果人们在服用LSD之前服用ketanserin，它会阻止迷幻的最强烈影响。 MindMed正在调查ketanserin是否可以在一个人已经采取LSD之后使用，以缩短或结束旅行。</p><p>  In February, MindMed announced that it was beginning a double-blind, placebo-controlled study, in collaboration with the University Hospital Basel, on ketanserin. “This study will support the patent application that was filed last year (preserving all worldwide rights) for a neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session,” according to their press release.</p><p>  2月份，MindMed宣布它正在与大学医院巴塞尔在Ketanserin合作开始进行双盲，安慰剂对照研究。 “本研究将支持去年提交的专利申请（保留所有全球权利）用于缩短和停止在治疗期间LSD行程的影响，”根据其新闻稿。</p><p>   As Psilocybin Alpha  noted, ketanserin was discovered by Janssen Pharmaceuticals, which was owned by J&amp;J, in 1980. “Whether this application of ketanserin will be effective, patentable, and profitable is yet to be seen,” Psilocybin Alpha wrote.</p><p>   作为psilocybin alpha alpha，ketanserin被janssen pharmaceuticals发现，由J ansensen j，1980年由J＆amp; J。“酮柳素的这种应用是否有效，可专利性和有利可图，”Psilocybin alpha写道。</p><p>   This ethereal  patent application is for a device that creates and maintains a “personalized bubble of scent&#34; around a person. While the scent bubble could be used for perfume, the application writes that other liquids could also be dispensed, including psychedelic medicines like LSD and psilocybin. Also on the list of potential ingredients for a personal bubble: human pheromones, insect repellant, anti-cellulite liquid, and vitamin-enhanced liquid.</p><p>   这种空灵专利申请是用于创造和维护“香味”的个性化泡沫的设备;在一个人身边。虽然气味泡沫可用于香水，但应用程序写入其他液体也可以分配，包括LSD和Psilocybin等荧光药物。此外，人类信息素，驱虫剂，抗脂肪酸液和维生素增强液体的潜在成分列表。</p><p>  Like the Philip Morris patents, these applications are not directly for the treatment of hair or tooth loss with psychedelics, but include psychedelics within the language of the patent application.</p><p>  与菲利普莫里斯专利一样，这些应用程序并非直接用于治疗荧光性或牙齿丧失，而是包括专利申请语言内的荧光学。</p><p>  The  periodontal application is primarily for a way to categorize patients with periodontal disease, and how to treat each patient accordingly. The hair loss patent application is about treating traction alopecia with compounds that have a specific kind of biological interaction with the scalp—and it includes DMT as one potential compound.</p><p>  牙周申请主要是为了一种分类牙周病患者的方法，以及如何相应治疗每位患者。脱发专利申请是用具有与头皮的特异性生物相互作用的化合物治疗牵引脱发，并且它包括DMT作为一种电位化合物。 </p><p>  This is something that we&#39;ll start to see more and more of, according to Casimir—psychedelics being folded into applications. “You tend to see this anytime someone has a successful product with something in the nutraceutical space,” he said. “You see a pile-on effect shortly thereafter—where everyone either speculates wildly and files patents on it, or collects some data to demonstrate it. I would expect as this topic gets more and more popular, which is not taking very long to happen, just about anything you could ever think of will be tried. And if it works, it&#39;ll be in the patent application. And sometimes even if it doesn&#39;t, it&#39;ll be in a patent application.”</p><p>根据Casimir-Falycedelics折叠成应用，这是我们＆＃39; ll开始看到越来越多的事情。 “如果有人在营养空间中有一些成功的产品，你倾向于看到这一点，”他说。 “你此后不久会看到一堆效果 - 每个人都在疯狂地推测它，并在其上提取专利，或收集一些数据以证明它。我会期待这一话题越来越受欢迎，这并没有很长时间发生，只是关于你可以想到的任何事情。如果它有效，它＆＃39; ll在专利申请中。有时候，即使它没有，它也没有，它＆＃39; ll在专利申请中。“</p><p>  Outside of concerns about cost, access, and monopoly, some feel that some of the latest patent applications contradict the focuses of academic psychedelic research. As Psymposia senior writer Russell Hausfeld  tweeted, “Funny. One of the biggest issues people are hoping psychedelics will help with is addiction. Meanwhile, Philip Morris is patenting DMT pens.” The multiple pending patent applications for weight loss are filed at the same time that Johns Hopkins is conducting research on the use of psychedelics for anorexia nervosa.</p><p>  在对成本，访问和垄断的担忧之外，有些人觉得一些最新的专利申请与学术迷幻研究的焦点相矛盾。作为psymposia高级作家罗素豪斯菲尔德推文，“有趣。人们希望迷幻的最大问题之一将有助于成瘾。与此同时，菲利普莫里斯是DMT钢笔的专利。“ Johns Hopkins正在进行关于对厌食症患者使用迷幻学的研究进行研究的同时提交了重量损失的多项待定专利申请。</p><p>  In a recent  article in Double Blind, lawyer Nicole Howell, who litigates in the cannabis market,  argued that there are important lessons psychedelics can learn from marijunana. “In cannabis, we’ve seen an unhealthy relationship with profit and investment that has created consolidation of the market, perverse incentives, and is slowly driving the lovers and believers out of the game only to be replaced by traditional business fundamentals of &#39;scale&#39;” &#39;ROI&#39; and ‘exit strategies,’” she wrote.</p><p>  在最近的双盲文章中，律师尼科尔·豪威尔在大麻市场上诉讼，认为有很重要的课程可以从Marijunana学习。 “在大麻中，我们已经看到了与盈利和投资的不健康的关系，这些关系已经创造了市场，经越激励措施，并且正在慢慢地将恋人和信徒从游戏中赶出，只能被传统的商业基础替换为＆＃39 ;规模＆＃39;“ ＆＃39; roi＆＃39;和“退出策略”，“她写道。</p><p>   Psychedelic researcher Matt Baggott  suggested one intriguing path forward: “We should also create the equivalent of creative commons psychedelic pharmacotherapy licenses. This would give rise to a coalition of organizations sharing IP that could outcompete the monopolists.”</p><p>   迷幻研究员Matt Baggott建议前进的一个有趣的道路：“我们还应该创造相当于创造性的Commons Psychendelic药物疗法许可证。这将导致组织共享IP的联盟，该联盟可以超越垄断者。“</p><p>  These patent growing pains will only increase in the coming years. And the culture around psychedelics particularly sets the field up for an ethical clash with how businesses normally go about profiting and making money from compounds. Howell wrote that “with psychedelics as our guide and teacher, we can and must challenge the false idol of cash as the prize and replace it with the notion that capital is the servant, catalyst, and partner to the ultimate reality that psychedelics reveal: We are one. This is the veil that is lifted when we tune in. This is the Great Perspective Shift psychedelics can offer.”</p><p>  这些专利的痛苦只会在未来几年增加。迷幻的文化尤其是与企业通常如何从化合物中获取利润和赚钱的行业的伦理冲突。 Howell写道，“与迷幻学为我们的指导和教师，我们可以并必须挑战现金的假偶像作为奖品，并将其替换为首都是仆人，催化剂和对荧光性揭示的最终现实的伙伴的概念：我们是一个。这是我们调整时被提升的面纱。这是良好的透视频率迷幻迷幻。“</p><p>  We&#39;ve rarely seen this kind of language deployed when discussing pharmaceutical IP. Clearly psychedelics and patent law represent a confrontation of differing values that may take awhile to figure out how to co-exist.</p><p>  我们很少看到在讨论药物IP时部署这种语言。显然，迷幻和专利法代表了不同价值观可能需要一段时间来弄清楚如何共存的价值观。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.vice.com/en/article/7k9359/the-race-to-patent-psychedelics-is-just-getting-started">https://www.vice.com/en/article/7k9359/the-race-to-patent-psychedelics-is-just-getting-started</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/比赛/">#比赛</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/patent/">#patent</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/专利/">#专利</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/谷歌/">#谷歌</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>